The short version of lyophilisation fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-02-10 and is reviewed periodically as new material appears.
Quality control for GHK-Cu relies on documentation and independent testing rather than a single accepted standard. A certificate of analysis may report peptide purity, copper content, residual solvents, water content, and microbial limits, but the underlying methods and acceptance criteria vary by supplier. Verification can include mass confirmation, amino acid analysis, and comparison with a reference standard when one is available. Open questions include how different copper-binding modes or peptide isomers affect measured activity and whether conventional purity assays capture those differences. Buyers of research-grade material typically need to request raw data rather than rely solely on a summary certificate.
Laboratory characterization of GHK-Cu typically combines separation, spectroscopic, and elemental techniques. Reverse-phase high-performance liquid chromatography is widely used to assess peptide purity, often with ultraviolet detection near the copper-related absorption band or with mass spectrometry for identity confirmation. Because the molecule contains copper, elemental methods such as inductively coupled plasma mass spectrometry or atomic absorption spectroscopy are used to quantify metal content and confirm stoichiometry. No single universal pharmacopeial monograph exists for GHK-Cu. Laboratories therefore validate their own methods, and reported purity values depend on the chosen assay and calibration standards.
Stability of GHK-Cu is influenced by light, oxygen, moisture, pH, and temperature. Solid material is generally kept desiccated and frozen to reduce hydrolysis and oxidation, while aqueous solutions are best prepared fresh or stored cold in aliquots. Repeated freeze-thaw cycles can promote aggregation, precipitation, or peptide degradation. Copper coordination may change under strongly acidic or alkaline conditions, potentially altering the complex's spectroscopic properties. Published long-term stability data for specific matrices, such as cosmetic emulsions or biological buffers, are limited, so shelf-life claims should be treated as formulation-specific rather than universal.
Analytical verification commonly relies on high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Spectroscopic methods such as UV-visible absorption and electron paramagnetic resonance can probe the metal centre itself, since the d9 configuration of copper(II) produces characteristic signals. Elemental analysis or plasma-based techniques quantify copper content. Because each method reports a different aspect of the same sample, purity figures are most meaningful when the technique and its detection wavelength are stated alongside the value.
Stability of the complex in solution depends on pH, temperature, and the presence of competing ligands. It is generally described as more resistant to breakdown than the metal-free chain, since coordination reduces susceptibility to enzymatic attack. Oxidation and hydrolysis can nevertheless proceed over time in aqueous media. Storage guidance in laboratory settings commonly involves refrigeration, protection from light, and avoidance of strongly alkaline conditions. Published data on long-term behaviour vary considerably and depend on the specific matrix.
| Property | Value | Notes |
|---|---|---|
| Primary identity method | Reverse-phase HPLC with mass spectrometry | Confirms peptide mass and retention behavior |
| Copper quantification | ICP-MS or atomic absorption spectroscopy | Measures metal content and stoichiometry |
| Spectroscopic feature | Visible absorption from copper(II) d-d transitions | Explains blue to blue-violet color |
| Recommended holding condition | Desiccated, protected from light, stored cold | Reduces hydrolysis, oxidation, and moisture uptake |
| Common purity check | HPLC area percent against a reference standard | Values depend on method and standard choice |
The sequence now called GHK was first reported in the early 1970s after isolation from human plasma, where it was noted to influence liver cell behavior in laboratory preparations. Later work described a copper-binding form and its activity in fibroblast and wound-model experiments. Review articles frequently group the substance with other copper peptides. Concentrations in blood appear to fall with age in several small surveys, although the reason for this trend is not settled. Whether such a decline carries functional consequences remains an open question.
Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, its terminal amino group, and a deprotonated amide nitrogen, creating a stable chelate ring. The resulting complex carries a distinctive blue to blue-violet color, which arises from copper d-d electronic transitions. In the solid state it is usually handled as a powder, while in solution the complex can dissociate and re-form depending on pH and competing ligands. The name copper tripeptide-1 is widely used in ingredient listings.
The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.
== Applications == Affibody molecules can be used for protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostic imaging and targeted therapy. The second generation of Affibody molecule, ABY-025, binds selectively to HER2 receptors with picomolar affinity. These Affibody molecules are in clinical development for tumor diagnosis. Anti-HER2 Affibody molecule, fused with albumin binding domain (ABD), denoted as ABY-027, labeled with Lutetium-177 provided reduction of renal and hepatic uptake of radioactivity in mice xenografts.. Further preclinical research evaluated an optimised version of the same ABD-fused Affibody, reporting an improved therapeutic effect in combination with trastuzumab. In October 2025, a refined variant of the ABD-fused Affibody molecule targeting HER2, radiolabelled with Lutetium-177, entered clinical trials to assess its safety, biodistribution and tolerability in patients with metastatic breast cancer. Recently, anti-ZEGFR Affibody ZEGFR:2377 labeled with technetium-99m was successfully used to visualize ZEGR expressing tumor in mice xenograft also.
By further optimizing the CNTs and CNT fibers, CNT fibers with improved electrical properties could be developed. CNT-based yarns are suitable for applications in energy and electrochemical water treatment when coated with an ion-exchange membrane. Also, CNT-based yarns could replace copper as a winding material. Pyrhönen et al. (2015) have built a motor using CNT winding.
=== Adrenal === Angiotensin II acts on the adrenal cortex, causing it to release aldosterone, a hormone that causes the kidneys to retain sodium and lose potassium. Elevated plasma angiotensin II levels are responsible for the elevated aldosterone levels present during the luteal phase of the menstrual cycle.
== Government investment and oversight == Between 2020 and 2024, the Ugandan government invested approximately UGX 723.4 billion in Dei BioPharma through multiple budget allocations. The investment sparked parliamentary scrutiny, with the Leader of the Opposition, Joel Ssenyonyi, questioning the absence of key documents such as a valuation by the Chief Government Valuer and a formal memorandum of understanding. The Auditor General’s report further raised concerns about the lack of share certificates and valuation documentation. In response to mounting questions, the company indicated a willingness to refund the investment, although no formal agreement had been reached as of late 2024.
== Third ministry == On 20 June 1972, following the 1972 election on 27 May, the Ministry was reconstituted by the Governor, Sir Colin Hannah, and served until the next reconstitution of the ministry on 23 December 1974. John Row retired from Parliament, and a further cabinet vacancy existed due to Delamothe's departure in December 1971. Keith Hooper and Henry McKechnie were appointed to fill the vacancies.
Sources: en.wikipedia.org
== Further reading == Louis Beres, Apocalypse: Nuclear Catastrophe in World Politics. The risks and consequences of nuclear war and nuclear terrorism. University of Chicago Press, Chicago, 1980. ISBN 9780226043609 Laura Grego and David Wright, "Broken Shield: Missiles designed to destroy incoming nuclear warheads fail frequently in tests and could increase global risk of mass destruction", Scientific American, vol. 320, no. no. 6 (June 2019), pp. 62–67. "Nuclear-armed missiles are a political problem that technology cannot solve.... Current U.S. missile defense plans are being driven largely by technology, politics and fear. Missile defenses will not allow us to escape our vulnerability to nuclear weapons. Instead large-scale developments will create barriers to taking real steps toward reducing nuclear risks—by blocking further cuts in nuclear arsenals and potentially spurring new deployments." (p. 67.) Jessica T. Mathews, "The New Nuclear Threat", The New York Review of Books, vol. LXVII, no. 13 (20 August 2020), pp. 19–21. "[P]owerful reasons to doubt that there could be a limited nuclear war [include] those that emerge from any study of history, a knowledge of how humans act under pressure, or experience of government." (p. 20.) National Academies of Sciences, Engineering, and Medicine. 2025. Potential Environmental Effects of Nuclear War. The National Academies Press. "Possibility of Nuclear War in Asia: An Indian Perspective", a project of United Service Institution of India, USI, Discusses the possibility of a nuclear war in Asia from the Indian point of view.
== Medical uses == In the US, galcanezumab is indicated in adults for the preventive treatment of migraine; and for the treatment of episodic cluster headache. In the EU, galcanezumab is indicated for the prophylaxis of migraine in adults who have at least four migraine days per month.
=== Freedom of expression === A devout advocate for democracy, Bhutto Zardari has repeatedly denounced censorship and likened any forms of curbing media freedom to living under a dictatorship. He made a speech at the Karachi Press Club on World Press Freedom Day where he said, "An undeclared censorship is stifling the freedom of expression in Pakistan and journalists are coming under threat from state and non-state actors." He added, "Journalists and media persons as human rights defenders suffer the most when freedom of expression is stifled. After the right to life, the most important right is the right of expression and the freedom of association because all other rights cannot even be articulated without it." During the speech, he also criticized the Prevention of Electronic Crime Act 2016 and stated that it had been misapplied to stifle dissent.
West Yorkshire is a metropolitan and ceremonial county in the Yorkshire and the Humber region of England. It borders North Yorkshire to the north and east, South Yorkshire and Derbyshire to the south, Greater Manchester to the south-west, and Lancashire to the west. The city of Leeds is the largest settlement. The county has an area of 2,029 km2 (783 sq mi) and had an estimated population of 2,435,236 in 2024. The centre of the county is urbanised. Leeds is in the north-east, the city of Wakefield in the south-east, Huddersfield in the south-west, and the city of Bradford in the north-west. The outer areas of the county are rural. For local government purposes the county comprises five metropolitan boroughs: Bradford, Calderdale, Kirklees, Leeds, and Wakefield, which collaborate through West Yorkshire Combined Authority. The county was created in 1974, prior to which the area was within the West Riding of Yorkshire. The western part of West Yorkshire is in the South Pennines, and contains a small part of the Peak District National Park. It is characterised by steep valleys and is the source of the River Calder, which flows past Wakefield before meeting the Aire, which flows through Leeds, near Castleford. The landscape becomes flatter in the east, and the eastern boundary of the county is on the edge of the Vale of York. Remnants of strong coal, wool and iron ore industries remain in the county, having attracted people over the centuries, and this can be seen in the buildings and architecture.
Sources: en.wikipedia.org
Identification usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. The copper content can be measured separately by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy. The combination helps distinguish the intact complex from free peptide or free copper.
Light, oxygen, moisture, extreme pH, and elevated temperature can promote degradation or change copper coordination. Aqueous solutions are more vulnerable than dry solid because water enables hydrolysis and oxidation. Freeze-thaw cycling can also reduce sample quality.
A certificate of analysis summarizes tests performed by a supplier, but it does not guarantee that the material is suitable for every use. Methods, limits, and reporting practices differ between laboratories. Independent verification or raw data review is often needed for critical applications.
Reverse-phase high-performance liquid chromatography with ultraviolet detection is the most common approach. Purity is expressed as a share of total peak area at a specified wavelength. Mass spectrometry is then used to confirm molecular identity.